A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6965232)

Published in Cancer Immunol Immunother on January 01, 1982

Authors

E Yarkoni1, J T Hunter, S Sukumar

Author Affiliations

1: Laboratory of Immunobiology, National Cancer Institute, Bethesda, MD 20205.

Articles by these authors

Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature (1985) 4.40

Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature (1984) 4.38

Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A (2000) 2.70

Molecular links between obesity and breast cancer. Endocr Relat Cancer (2006) 2.44

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene (2011) 2.42

RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev (1994) 2.17

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet (2001) 2.16

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res (2001) 1.95

Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry (2004) 1.92

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89

Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res (1999) 1.74

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res (2001) 1.73

Activation of ras oncogenes preceding the onset of neoplasia. Science (1990) 1.68

Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A (1991) 1.65

Improving the standard of operation notes in orthopaedic and trauma surgery: the value of a proforma. Injury (2004) 1.54

Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene (2000) 1.40

A single mutation is responsible for the high prevalence of G6PD deficiency in the Vataliya Prajapatis--an endogamous caste group from Western India. Am J Hematol (2001) 1.37

HOXA5 regulates expression of the progesterone receptor. J Biol Chem (2000) 1.28

Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA. PCR Methods Appl (1992) 1.17

Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. Am J Clin Nutr (1995) 1.16

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol (2008) 1.12

Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res (1997) 1.05

HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene (2007) 1.05

Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors. Mol Cell Biol (1986) 1.03

Activation of H-ras oncogenes in preneoplastic mouse mammary tissues. Oncogene (1990) 1.02

Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res (1999) 1.00

Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J (1999) 1.00

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res (1999) 1.00

Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res (1994) 0.96

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int J Oncol (2001) 0.96

A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens. Science (1984) 0.95

A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Proc Natl Acad Sci U S A (1994) 0.95

Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumors induced in F344 rats by methyl(methoxymethyl)nitrosamine. Mol Cell Biol (1986) 0.94

Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res (1992) 0.94

Telomerase activity in ductal carcinoma in situ and invasive breast cancer. Oncogene (1999) 0.94

Peripheral plasma progesterone and utero-ovarian prostaglandin F concentrations in the cow around parturition. Prostaglandins (1975) 0.93

High prevalence of G6PD deficiency in Vataliya Prajapati community in western India. Haematologia (Budap) (2001) 0.91

ras oncogenes in chemical carcinogenesis. Curr Top Microbiol Immunol (1989) 0.91

CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res (2001) 0.88

Transforming c-Ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea. Mol Cell Biol (1990) 0.87

Foetal and maternal hormonal changes preceding normal bovine parturition. Acta Endocrinol (Copenh) (1977) 0.85

Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers. Clin Cancer Res (1998) 0.85

Applications of telomerase research in the fight against cancer. Mol Med Today (1999) 0.85

Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery. Cancer Res (1980) 0.85

Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery. Cancer Res (1979) 0.85

Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter. Biochem Mol Med (1997) 0.84

Molecular cloning and chromosomal localization of Chinese hamster telomeric protein chTRF1. Its potential role in chromosomal instability. Oncogene (1998) 0.82

Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations. Clin Cancer Res (1997) 0.82

Donate organs not malignancies: postoperative small cell lung carcinoma in a marginal living kidney donor. Transplant Proc (2007) 0.82

Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery (1997) 0.82

Study of antiviral activity of tender leaves of Margosa tree (Melia azadericta) on vaccinia and variola virus: a preliminary report. Indian J Med Res (1969) 0.82

Telomerase activity and prognosis in primary breast cancers. J Clin Oncol (1999) 0.82

Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG). J Natl Cancer Inst (1978) 0.81

Flexible sigmoidoscopy does not significantly increase polyp and cancer detection yield when used to supplement CT colonography. Digestion (2011) 0.81

Multistage prostate carcinogenesis: the role of hormones. Princess Takamatsu Symp (1991) 0.81

An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation. Leukemia (2003) 0.81

Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery. J Natl Cancer Inst (1977) 0.81

Dendritic-NK cell interactions in P. gingivalis-specific responses. J Dent Res (2005) 0.80

Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice. J Natl Cancer Inst (1978) 0.80

Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells. Cancer Res (1980) 0.79

Parallel cousin marriages in Madras, Tamil Nadu: new trends in Dravidian kinship. Soc Biol (1990) 0.79

Telomerase activity in the normal and neoplastic rat mammary gland. Cancer Res (1997) 0.79

Interspecific rice hybrid of Oryza sativa x Oryza nivara reveals a significant increase in seed protein content. J Agric Food Chem (2007) 0.79

Conservative management of a pelvic Schwannoma presenting as an adnexal mass. J Obstet Gynaecol (2008) 0.79

G6PD deficiency and malaria in India. Am J Hematol (2003) 0.78

Vector PCR. Biotechniques (1991) 0.78

Mechanisms of immunological eradication of a syngeneic guinea pig tumor. II. Effect of methotrexate treatment and T cell depletion of the recipient on adoptive immunity. Transplantation (1983) 0.78

Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles. Anticancer Res (1994) 0.77

Dexamethasone concentrations in plasma and milk of cows following the injection of long- and short-acting dexamethasone esters. Aust J Biol Sci (1981) 0.77

Absence of TSG101 transcript abnormalities in human cancers. Oncogene (1998) 0.77

Midkine in the progression of rat N-nitroso-N-methylurea-induced mammary tumors. Mol Carcinog (1996) 0.76

Anaesthesia in Thoracic Surgery. Br Med J (1939) 0.75

Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer. J Exp Med (1981) 0.75

Use of the nude mouse in immunological research. Methods Enzymol (1984) 0.75

Correspondence re: Mills SE, Kempson RL, Fechner RE, et al.: Guardians of the wax ... and the patient. Mod Pathol 8:699, 1995. Mod Pathol (1996) 0.75

Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG. Infect Immun (1979) 0.75

Treatment of mice with lung metastasis from a dermally implanted fibrosarcoma: comparison of intratumoral trehalose-6,6'-dimycolate (cord factor) and surgery. Eur J Cancer (1981) 0.75

Activation of H-ras-1 oncogenes by chemical carcinogens. Basic Life Sci (1986) 0.75

Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions. Cancer Res (1981) 0.75

Preparation HOE 105 (citenazone) in chemoprophylaxis of variola in monkeys: a preliminary communication. Indian J Med Res (1973) 0.75

Nude mice of different strains in parabiosis for prolonged periods of time. Exp Cell Biol (1984) 0.75

Molecular assays for detection of ras oncogenes in human and animal tumors. Carcinog Compr Surv (1985) 0.75

Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas. Hybridoma (1991) 0.75

Plasma concentrations of progesterone, oestrogens and prostaglandin F in maternal blood and corticosteroids and oestrogens in foetal blood of cows during dexamethasone-induced deliveries. Acta Endocrinol (Copenh) (1981) 0.75

A study of viral fever in the city of Madras. J Assoc Physicians India (1975) 0.75

Fetal and maternal plasma electrolytes, blood gases, and pH in dairy cows during late gestation. J Dairy Sci (1977) 0.75

Preparturient changes in plasma concentrations of estrone, estradiol-17beta and estradiol-17alpha in the fetal calf: effects of dexamethasone infusion. Steroids (1976) 0.75

Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity. J Natl Cancer Inst (1982) 0.75

Fetal and maternal mineral concentrations in dairy cattle during late pregnancy. J Dairy Sci (1977) 0.75

Mitigation of environmental impacts due to ghat road formation in Palamalai Hills, South India, by optimizing cut and fill volumes using GPS and GIS techniques. Environ Monit Assess (2014) 0.75

Outburst of Jupiter's synchrotron radiation after the impact of comet Shoemaker-Levy 9. Science (1995) 0.75

Eradication of microscopic hepatic metastases by active specific immunization. Cancer Immunol Immunother (1983) 0.75

Molecular mechanisms of chemical carcinogenesis in rodent models. Cancer Treat Res (1994) 0.75

Clinical examination and hematological data in asymptomatic & apparently healthy school children in a boarding school in a tribal area. Indian J Public Health (2003) 0.75

Effect of various therapeutic treatments on polyamine contents in experimental fibrosarcoma. Indian J Biochem Biophys (1978) 0.75

Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma. Cancer Res (1984) 0.75

Molecular genetics of human breast cancer. Prog Clin Biol Res (1996) 0.75

Activation of ras oncogenes by chemical carcinogens. Gene Amplif Anal (1986) 0.75